BioCentury | Apr 15, 2013
Company News

Senetek management update

Senetek PLC (SNTKY), New York, N.Y. Business: Reproductive Promoted: Cliff Brune as group president and COO, while remaining CFO; David Carey as VP of finance, formerly VP of finance for SNTKY's Carme Cosmeceutical Sciences Corp....
BioCentury | Apr 15, 2013
Clinical News

Invicorp autoinjection of vasoactive intestinal polypeptide data

...be presented in Madrid at the October meeting of the European Society for Impotence Research. Senetek plc...
BioCentury | Apr 15, 2013
Clinical News

Kinetin N6-furfuryladenine plant growth hormone data

...Mill Creek Botanicals Age Defiant Skin Preservation System by SNTKY's Carme Cosmeceutical Sciences business unit. Senetek PLC...
BioCentury | Nov 2, 2009
Company News

Senetek genitourinary news

...disposition of one or more corporate assets, a potential merger and/or a strategic business combination. Senetek's...
...Solutions Holdings plc (LSE:PLE, London, U.K.) in the North America to treat erectile dysfunction (ED). Senetek...
...30, Senetek had $13 million in cash and a six-month operating loss of $2.5 million. Senetek plc...
BioCentury | Dec 22, 2008
Company News

Senetek, Polish Academy of Sciences deal

...The academy granted Senetek exclusive, worldwide rights to a technology that inhibits an undisclosed cancer target...
...undisclosed cancer target using RNA interference (RNAi). The academy is eligible for royalties. In 2006, Senetek...
...academy to another RNAi cancer candidate and three dermatology compounds (see BioCentury, Nov. 13, 2006). Senetek plc...
BioCentury | Jul 14, 2008
Company News

Ardana, Senetek deal

...distribute Senetek’s Invicorp vasoactive intestinal polypeptide (VIP)/phentolamine injection in Europe to treat erectile dysfunction (ED). Senetek...
...into administration last month. The product is marketed in Denmark, New Zealand and the U.K. Senetek...
...North America. (see BioCentury, June 28, 2004, & June 30). Ardana plc (LSE:ARA), Edinburgh, U.K. Senetek plc...
BioCentury | Jul 7, 2008
Company News

Ardana genitourinary news

...Switzerland); to Striant SR from Columbia Laboratories Inc. (NASDAQ:CBRX; Livingston, N.J.); and to Invicorp from Senetek plc...
BioCentury | Jun 16, 2008
Company News

Senetek management update

Senetek plc (OTCBB:SNKTY), Napa, Calif. Business: Drug delivery, Genitourinary, Dermatology Hired: Phillip Rose as COO, formerly president and CEO of Obagi Medical Products Inc. WIR Staff Dermatology Genitourinary...
BioCentury | Apr 23, 2007
Clinical News

Pyratine 6: Pilot trial started

...SNTKY began a pilot trial in 24 patients. Senetek plc (SNTKY), Napa, Calif. Product: Pyratine 6...
BioCentury | Mar 5, 2007
Clinical News

Invicorp: Phase III start

...and the U.K. Ardana plc (LSE:ARA), Edinburgh, U.K. Plethora Solutions Holdings plc (LSE:PLE), London, U.K. Senetek plc...
Items per page:
1 - 10 of 94
BioCentury | Apr 15, 2013
Company News

Senetek management update

Senetek PLC (SNTKY), New York, N.Y. Business: Reproductive Promoted: Cliff Brune as group president and COO, while remaining CFO; David Carey as VP of finance, formerly VP of finance for SNTKY's Carme Cosmeceutical Sciences Corp....
BioCentury | Apr 15, 2013
Clinical News

Invicorp autoinjection of vasoactive intestinal polypeptide data

...be presented in Madrid at the October meeting of the European Society for Impotence Research. Senetek plc...
BioCentury | Apr 15, 2013
Clinical News

Kinetin N6-furfuryladenine plant growth hormone data

...Mill Creek Botanicals Age Defiant Skin Preservation System by SNTKY's Carme Cosmeceutical Sciences business unit. Senetek PLC...
BioCentury | Nov 2, 2009
Company News

Senetek genitourinary news

...disposition of one or more corporate assets, a potential merger and/or a strategic business combination. Senetek's...
...Solutions Holdings plc (LSE:PLE, London, U.K.) in the North America to treat erectile dysfunction (ED). Senetek...
...30, Senetek had $13 million in cash and a six-month operating loss of $2.5 million. Senetek plc...
BioCentury | Dec 22, 2008
Company News

Senetek, Polish Academy of Sciences deal

...The academy granted Senetek exclusive, worldwide rights to a technology that inhibits an undisclosed cancer target...
...undisclosed cancer target using RNA interference (RNAi). The academy is eligible for royalties. In 2006, Senetek...
...academy to another RNAi cancer candidate and three dermatology compounds (see BioCentury, Nov. 13, 2006). Senetek plc...
BioCentury | Jul 14, 2008
Company News

Ardana, Senetek deal

...distribute Senetek’s Invicorp vasoactive intestinal polypeptide (VIP)/phentolamine injection in Europe to treat erectile dysfunction (ED). Senetek...
...into administration last month. The product is marketed in Denmark, New Zealand and the U.K. Senetek...
...North America. (see BioCentury, June 28, 2004, & June 30). Ardana plc (LSE:ARA), Edinburgh, U.K. Senetek plc...
BioCentury | Jul 7, 2008
Company News

Ardana genitourinary news

...Switzerland); to Striant SR from Columbia Laboratories Inc. (NASDAQ:CBRX; Livingston, N.J.); and to Invicorp from Senetek plc...
BioCentury | Jun 16, 2008
Company News

Senetek management update

Senetek plc (OTCBB:SNKTY), Napa, Calif. Business: Drug delivery, Genitourinary, Dermatology Hired: Phillip Rose as COO, formerly president and CEO of Obagi Medical Products Inc. WIR Staff Dermatology Genitourinary...
BioCentury | Apr 23, 2007
Clinical News

Pyratine 6: Pilot trial started

...SNTKY began a pilot trial in 24 patients. Senetek plc (SNTKY), Napa, Calif. Product: Pyratine 6...
BioCentury | Mar 5, 2007
Clinical News

Invicorp: Phase III start

...and the U.K. Ardana plc (LSE:ARA), Edinburgh, U.K. Plethora Solutions Holdings plc (LSE:PLE), London, U.K. Senetek plc...
Items per page:
1 - 10 of 94